TreeWAS – Variant ID: rs4713340

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
E10.9 Without complications	0.000	0.193	0.807
E10 Insulin-dependent diabetes mellitus	0.000	0.213	0.787
E10.1 With ketoacidosis	0.000	0.262	0.738
E10.3 With ophthalmic complications	0.000	0.292	0.708
E10.4 With neurological complications	0.000	0.326	0.674
E10.2 With renal complications	0.000	0.369	0.631
E10.5 With peripheral circulatory complications	0.000	0.400	0.600
E10.8 With unspecified complications	0.000	0.436	0.564
E10.7 With multiple complications	0.000	0.436	0.564
E10.6 With other specified complications	0.000	0.436	0.564
E10.0 With coma	0.000	0.436	0.564
K90 Intestinal malabsorption	0.000	0.804	0.196
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.831	0.169
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.834	0.166
C85.1 B-cell lymphoma, unspecified	0.000	0.841	0.159
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.858	0.142
K90.3 Pancreatic steatorrhoea	0.000	0.859	0.141
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.859	0.141
K90.1 Tropical sprue	0.000	0.859	0.141
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.860	0.140
E10-E14 Diabetes mellitus	0.000	0.861	0.139
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.866	0.134
C83.3 Large cell (diffuse)	0.000	0.866	0.134
K90.8 Other intestinal malabsorption	0.000	0.870	0.130
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.870	0.130
C83.0 Small cell (diffuse)	0.000	0.876	0.124
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.880	0.119
C85.0 Lymphosarcoma	0.000	0.880	0.119
C83.1 Small cleaved cell (diffuse)	0.000	0.882	0.118
C88 Malignant immunoproliferative diseases	0.000	0.883	0.117
C92 Myeloid leukaemia	0.000	0.888	0.112
E13 Other specified diabetes mellitus	0.000	0.889	0.111
C91 Lymphoid leukaemia	0.000	0.890	0.110
C93 Monocytic leukaemia	0.000	0.898	0.102
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.898	0.102
C95 Leukaemia of unspecified cell type	0.000	0.898	0.102
C94 Other leukaemias of specified cell type	0.000	0.898	0.102
C86 Other specified types of T/NK-cell lymphoma	0.000	0.898	0.102
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.899	0.101
C83.6 Undifferentiated (diffuse)	0.000	0.899	0.100
C83.5 Lymphoblastic (diffuse)	0.000	0.899	0.100
C83.4 Immunoblastic (diffuse)	0.000	0.899	0.100
C83.2 Mixed small and large cell (diffuse)	0.000	0.899	0.100
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.900	0.100
E12 Malnutrition-related diabetes mellitus	0.000	0.900	0.100
C83.7 Burkitt's tumour	0.000	0.901	0.099
C91.1 Chronic lymphocytic leukaemia	0.000	0.901	0.099
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.904	0.096
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.905	0.095
C92.0 Acute myeloid leukaemia	0.000	0.908	0.092
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.908	0.092
E13.9 Without complications	0.000	0.909	0.091
C92.1 Chronic myeloid leukaemia	0.000	0.915	0.085
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.916	0.084
C88.7 Other malignant immunoproliferative diseases	0.000	0.916	0.084
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.916	0.084
C88.3 Immunoproliferative small intestinal disease	0.000	0.916	0.084
C88.2 Gamma heavy chain disease	0.000	0.916	0.084
C88.1 Alpha heavy chain disease	0.000	0.916	0.084
C92.9 Myeloid leukaemia, unspecified	0.000	0.919	0.081
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.919	0.081
C92.7 Other myeloid leukaemia	0.000	0.919	0.081
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.919	0.081
C92.5 Acute myelomonocytic leukaemia	0.000	0.919	0.081
C92.3 Myeloid sarcoma	0.000	0.919	0.081
C92.2 Subacute myeloid leukaemia	0.000	0.919	0.081
C90.2 Plasmacytoma, extramedullary	0.000	0.919	0.081
E14 Unspecified diabetes mellitus	0.000	0.920	0.080
C91.9 Lymphoid leukaemia, unspecified	0.000	0.920	0.080
E13.8 With unspecified complications	0.000	0.920	0.079
E13.7 With multiple complications	0.000	0.920	0.079
E13.6 With other specified complications	0.000	0.920	0.079
E13.5 With peripheral circulatory complications	0.000	0.920	0.079
E13.4 With neurological complications	0.000	0.920	0.079
E13.3 With ophthalmic complications	0.000	0.920	0.079
E13.2 With renal complications	0.000	0.920	0.079
E13.1 With ketoacidosis	0.000	0.920	0.079
E13.0 With coma	0.000	0.920	0.079
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.921	0.079
C91.7 Other lymphoid leukaemia	0.000	0.921	0.079
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.921	0.079
C91.3 Prolymphocytic leukaemia	0.000	0.921	0.079
C91.2 Subacute lymphocytic leukaemia	0.000	0.921	0.079
C91.4 Hairy-cell leukaemia	0.000	0.924	0.075
C93.1 Chronic monocytic leukaemia	0.000	0.926	0.074
C92.4 Acute promyelocytic leukaemia	0.000	0.927	0.073
C93.9 Monocytic leukaemia, unspecified	0.000	0.927	0.073
C93.7 Other monocytic leukaemia	0.000	0.927	0.073
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.927	0.073
C93.2 Subacute monocytic leukaemia	0.000	0.927	0.073
C93.0 Acute monocytic leukaemia	0.000	0.927	0.073
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.927	0.073
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.927	0.073
C86.4 Blastic NK-cell lymphoma	0.000	0.927	0.073
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.927	0.073
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.927	0.073
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.927	0.073
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.927	0.073
C94.7 Other specified leukaemias	0.000	0.927	0.073
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.927	0.073
C94.5 Acute myelofibrosis	0.000	0.927	0.073
C94.4 Acute panmyelosis	0.000	0.927	0.073
C94.3 Mast cell leukaemia	0.000	0.927	0.073
C94.2 Acute megakaryoblastic leukaemia	0.000	0.927	0.073
C94.1 Chronic erythraemia	0.000	0.927	0.073
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.927	0.073
C95.9 Leukaemia, unspecified	0.000	0.927	0.073
C95.7 Other leukaemia of unspecified cell type	0.000	0.927	0.073
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.927	0.073
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.927	0.073
C95.0 Acute leukaemia of unspecified cell type	0.000	0.927	0.073
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.927	0.073
C96.8 Histiocytic sarcoma	0.000	0.927	0.073
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.927	0.073
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.927	0.073
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.927	0.073
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.927	0.073
C96.3 True histiocytic lymphoma	0.000	0.927	0.073
C96.2 Malignant mast cell tumour	0.000	0.927	0.073
C96.1 Malignant histiocytosis	0.000	0.927	0.073
C96.0 Letterer-Siwe disease	0.000	0.927	0.073
C90.3 Solitary plasmacytoma	0.000	0.927	0.073
E12.9 Without complications	0.000	0.928	0.072
E12.8 With unspecified complications	0.000	0.928	0.072
E12.7 With multiple complications	0.000	0.928	0.072
E12.6 With other specified complications	0.000	0.928	0.072
E12.5 With peripheral circulatory complications	0.000	0.928	0.072
E12.4 With neurological complications	0.000	0.928	0.072
E12.3 With ophthalmic complications	0.000	0.928	0.072
E12.2 With renal complications	0.000	0.928	0.072
E12.1 With ketoacidosis	0.000	0.928	0.072
E12.0 With coma	0.000	0.928	0.072
C84.5 Other and unspecified T-cell lymphomas	0.000	0.930	0.070
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.930	0.070
C84.0 Mycosis fungoides	0.000	0.930	0.069
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.931	0.069
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.931	0.069
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.931	0.069
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.931	0.069
C84.3 Lymphoepithelioid lymphoma	0.000	0.931	0.069
C84.2 T-zone lymphoma	0.000	0.931	0.069
C84.1 Sezary's diease	0.000	0.931	0.069
K90.9 Intestinal malabsorption, unspecified	0.001	0.931	0.068
C91.0 Acute lymphoblastic leukaemia	0.000	0.932	0.068
C90.0 Multiple myeloma	0.000	0.932	0.068
C90.1 Plasma cell leukaemia	0.000	0.932	0.067
R31 Unspecified haematuria	0.067	0.933	0.000
E14.3 With ophthalmic complications	0.000	0.935	0.065
C91.5 Adult T-cell leukaemia	0.000	0.936	0.064
C84.4 Peripheral T-cell lymphoma	0.000	0.938	0.062
C81 Hodgkin's disease	0.000	0.940	0.060
E14.4 With neurological complications	0.000	0.942	0.058
E14.7 With multiple complications	0.000	0.942	0.058
E14.6 With other specified complications	0.000	0.942	0.058
E14.5 With peripheral circulatory complications	0.000	0.942	0.058
E14.2 Withrenal complications	0.000	0.942	0.058
E14.0 With coma	0.000	0.942	0.058
E14.8 With unspecified complications	0.000	0.945	0.055
E14.1 With ketoacidosis	0.000	0.946	0.054
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.947	0.053
C82.6 Cutaneous follicle centre lymphoma	0.000	0.950	0.050
C82.5 Diffuse follicle centre lymphoma	0.000	0.950	0.050
C82.4 Follicular lymphoma grade IIIb	0.000	0.950	0.050
C82.3 Follicular lymphoma grade IIIa	0.000	0.950	0.050
C82.0 Small cleaved cell, follicular	0.000	0.950	0.050
C82.2 Large cell, follicular	0.000	0.953	0.047
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.955	0.044
C81.7 Other Hodgkin's disease	0.000	0.957	0.043
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.957	0.043
C81.3 Lymphocytic depletion	0.000	0.957	0.043
C81.2 Mixed cellularity	0.000	0.957	0.043
C81.0 Lymphocytic predominance	0.000	0.958	0.042
C81.1 Nodular sclerosis	0.000	0.965	0.034
E05.9 Thyrotoxicosis, unspecified	0.000	0.965	0.035
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.968	0.032
E14.9 Without complications	0.000	0.970	0.030
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.976	0.024
C81.9 Hodgkin's disease, unspecified	0.001	0.977	0.022
K90-K93 Other diseases of the digestive system	0.000	0.979	0.021
D50.9 Iron deficiency anaemia, unspecified	0.000	0.980	0.020
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.982	0.018
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.982	0.018
E05.8 Other thyrotoxicosis	0.000	0.982	0.018
E05.5 Thyroid crisis or storm	0.000	0.983	0.017
E05.4 Thyrotoxicosis factitia	0.000	0.983	0.017
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.983	0.017
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.983	0.017
K93 Disorders of other digestive organs in diseases classified elsewhere	0.000	0.984	0.016
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.986	0.014
E00-E07 Disorders of thyroid gland	0.000	0.987	0.013
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.988	0.012
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.000	0.988	0.011
K93.1 Megacolon in Chagas' disease	0.000	0.988	0.011
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.000	0.988	0.011
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.011	0.989	0.000
D50 Iron deficiency anaemia	0.000	0.989	0.011
E16 Other disorders of pancreatic internal secretion	0.000	0.989	0.011
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.990	0.010
E16.2 Hypoglycaemia, unspecified	0.000	0.990	0.010
E40-E46 Malnutrition	0.000	0.990	0.010
R40.2 Coma, unspecified	0.000	0.990	0.010
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.991	0.009
E00 Congenital iodine-deficiency syndrome	0.000	0.991	0.009
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.991	0.009
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.991	0.009
K91.1 Postgastric surgery syndromes	0.000	0.991	0.009
E15 Nondiabetic hypoglycaemic coma	0.000	0.991	0.009
M45.X9 Ankylosing spondylitis (Site unspecified)	0.009	0.991	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.991	0.009
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.992	0.008
K91.3 Postoperative intestinal obstruction	0.000	0.992	0.008
N10 Acute tubulo-interstitial nephritis	0.008	0.992	0.000
D50.1 Sideropenic dysphagia	0.000	0.992	0.008
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.992	0.008
E07 Other disorders of thyroid	0.000	0.992	0.008
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.992	0.008
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.992	0.008
E16.4 Abnormal secretion of gastrin	0.000	0.992	0.008
E16.3 Increased secretion of glucagon	0.000	0.992	0.008
K91.5 Postcholecystectomy syndrome	0.000	0.992	0.008
D50.8 Other iron deficiency anaemias	0.000	0.992	0.008
E16.1 Other hypoglycaemia	0.000	0.992	0.007
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.993	0.007
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.993	0.007
E45 Retarded development following protein-energy malnutrition	0.000	0.993	0.007
E43 Unspecified severe protein-energy malnutrition	0.000	0.993	0.007
E42 Marasmic kwashiorkor	0.000	0.993	0.007
E41 Nutritional marasmus	0.000	0.993	0.007
E40 Kwashiorkor	0.000	0.993	0.007
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.993	0.007
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.993	0.007
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.993	0.007
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.993	0.007
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.993	0.007
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.993	0.007
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.993	0.007
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.993	0.007
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.993	0.007
I65.2 Occlusion and stenosis of carotid artery	0.000	0.993	0.007
E46 Unspecified protein-energy malnutrition	0.000	0.993	0.007
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.993	0.007
E65-E68 Obesity and other hyperalimentation	0.000	0.993	0.007
E06 Thyroiditis	0.000	0.993	0.007
M45.X2 Ankylosing spondylitis (Cervical region)	0.007	0.993	0.000
M45 Ankylosing spondylitis	0.007	0.993	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.007	0.993	0.000
E07.8 Other specified disorders of thyroid	0.000	0.994	0.006
E07.1 Dyshormogenetic goitre	0.000	0.994	0.006
E07.0 Hypersecretion of calcitonin	0.000	0.994	0.006
T36-T50 Poisoning by drugs, medicaments and biological substances	0.006	0.994	0.000
E50-E64 Other nutritional deficiencies	0.000	0.994	0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.006	0.994	0.000
R30-R39 Symptoms and signs involving the urinary system	0.006	0.994	0.000
T42.1 Iminostilbenes	0.006	0.994	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
E44.1 Mild protein-energy malnutrition	0.000	0.995	0.005
E44.0 Moderate protein-energy malnutrition	0.000	0.995	0.005
E65 Localised adiposity	0.000	0.995	0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
K61.0 Anal abscess	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
E67 Other hyperalimentation	0.000	0.995	0.005
E68 Sequelae of hyperalimentation	0.000	0.995	0.005
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.005	0.995	0.000
E06.5 Other chronic thyroiditis	0.000	0.995	0.005
E06.4 Drug-induced thyroiditis	0.000	0.995	0.005
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.995	0.005
E06.1 Subacute thyroiditis	0.000	0.995	0.005
E06.0 Acute thyroiditis	0.000	0.995	0.005
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.005	0.995	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.005	0.995	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.005	0.995	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.005	0.995	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.005	0.995	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
J32.9 Chronic sinusitis, unspecified	0.005	0.995	0.000
T39.4 Antirheumatics, not elsewhere classified	0.005	0.995	0.000
T39.2 Pyrazolone derivatives	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
E03 Other hypothyroidism	0.000	0.995	0.005
E27.1 Primary adrenocortical insufficiency	0.000	0.995	0.005
R30 Pain associated with micturition	0.005	0.995	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.000	0.995	0.005
T42.0 Hydantoin derivatives	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.995	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.995	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.995	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.995	0.000
T36 Poisoning by systemic antibiotics	0.004	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.995	0.000
D23.6 Skin of upper limb, including shoulder	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.996	0.004
E63 Other nutritional deficiencies	0.000	0.996	0.004
E56 Other vitamin deficiencies	0.000	0.996	0.004
E50 Vitamin A deficiency	0.000	0.996	0.004
E60 Dietary zinc deficiency	0.000	0.996	0.004
E59 Dietary selenium deficiency	0.000	0.996	0.004
E58 Dietary calcium deficiency	0.000	0.996	0.004
E54 Ascorbic acid deficiency	0.000	0.996	0.004
E52 Niacin deficiency [pellagra]	0.000	0.996	0.004
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
R33 Retention of urine	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
R36 Urethral discharge	0.004	0.996	0.000
E04 Other non-toxic goitre	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
E51 Thiamine deficiency	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
E06.9 Thyroiditis, unspecified	0.000	0.996	0.004
R30.0 Dysuria	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.996	0.004
N32.3 Diverticulum of bladder	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
K25 Gastric ulcer	0.000	0.996	0.004
E67.8 Other specified hyperalimentation	0.000	0.996	0.004
E67.3 Hypervitaminosis D	0.000	0.996	0.004
E67.2 Megavitamin-B6 syndrome	0.000	0.996	0.004
E67.1 Hypercarotenaemia	0.000	0.996	0.004
E67.0 Hypervitaminosis A	0.000	0.996	0.004
E53 Deficiency of other B group vitamins	0.000	0.996	0.004
D50-D53 Nutritional anaemias	0.000	0.996	0.004
E20-E35 Disorders of other endocrine glands	0.000	0.996	0.004
K25.7 Chronic without haemorrhage or perforation	0.000	0.996	0.004
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
E11 Non-insulin-dependent diabetes mellitus	0.000	0.996	0.004
R30.9 Painful micturition, unspecified	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
E03.5 Myxoedema coma	0.000	0.996	0.004
E03.4 Atrophy of thyroid (acquired)	0.000	0.996	0.004
E03.3 Postinfectious hypothyroidism	0.000	0.996	0.004
E03.1 Congenital hypothyroidism without goitre	0.000	0.996	0.004
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
E06.3 Autoimmune thyroiditis	0.000	0.996	0.004
R39 Other symptoms and signs involving the urinary system	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.996	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.000	0.996	0.003
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.000	0.996	0.003
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.000	0.996	0.003
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.000	0.996	0.003
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.000	0.996	0.003
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.000	0.996	0.003
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.000	0.996	0.003
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.000	0.996	0.003
E27 Other disorders of adrenal gland	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.996	0.000
T47.7 Emetics	0.003	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.996	0.000
T47.5 Digestants	0.003	0.996	0.000
T47.4 Other laxatives	0.003	0.996	0.000
T47.3 Saline and osmotic laxatives	0.003	0.996	0.000
T47.2 Stimulant laxatives	0.003	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.996	0.000
E55 Vitamin D deficiency	0.000	0.996	0.004
T36.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
T36.8 Other systemic antibiotics	0.003	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
T36.6 Rifamycins	0.003	0.996	0.000
T36.5 Aminoglycosides	0.003	0.996	0.000
T36.4 Tetracyclines	0.003	0.996	0.000
T36.3 Macrolides	0.003	0.996	0.000
T36.2 Chloramphenicol group	0.003	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.996	0.000
T37.5 Antiviral drugs	0.003	0.996	0.000
T37.4 Anthelminthics	0.003	0.996	0.000
T37.3 Other antiprotozoal drugs	0.003	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.996	0.000
T37.1 Antimycobacterial drugs	0.003	0.996	0.000
T37.0 Sulphonamides	0.003	0.996	0.000
T41.5 Therapeutic gases	0.003	0.996	0.000
T41.4 Anaesthetic, unspecified	0.003	0.996	0.000
T41.3 Local anaesthetics	0.003	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.996	0.000
T41.1 Intravenous anaesthetics	0.003	0.996	0.000
T41.0 Inhaled anaesthetics	0.003	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.996	0.000
T48.5 Anti-common-cold drugs	0.003	0.996	0.000
T48.4 Expectorants	0.003	0.996	0.000
T48.3 Antitussives	0.003	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.996	0.000
T48.0 Oxytocic drugs	0.003	0.996	0.000
T49.9 Topical agent, unspecified	0.003	0.996	0.000
T49.8 Other topical agents	0.003	0.996	0.000
T49.7 Dental drugs, topically applied	0.003	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.996	0.000
T49.2 Local astringents and local detergents	0.003	0.996	0.000
T49.1 Antipruritics	0.003	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.996	0.000
T36.0 Penicillins	0.003	0.996	0.000
T40.5 Cocaine	0.003	0.996	0.000
E04.0 Non-toxic diffuse goitre	0.000	0.996	0.003
T50.8 Diagnostic agents	0.003	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.996	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
T50.5 Appetite depressants	0.003	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
E20 Hypoparathyroidism	0.000	0.997	0.003
E50.9 Vitamin A deficiency, unspecified	0.000	0.997	0.003
E50.8 Other manifestations of vitamin A deficiency	0.000	0.997	0.003
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.997	0.003
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.997	0.003
E50.5 Vitamin A deficiency with night blindness	0.000	0.997	0.003
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.997	0.003
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.997	0.003
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.997	0.003
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.997	0.003
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.997	0.003
E56.9 Vitamin deficiency, unspecified	0.000	0.997	0.003
E56.8 Deficiency of other vitamins	0.000	0.997	0.003
E56.1 Deficiency of vitamin K	0.000	0.997	0.003
E56.0 Deficiency of vitamin E	0.000	0.997	0.003
E63.9 Nutritional deficiency, unspecified	0.000	0.997	0.003
E63.8 Other specified nutritional deficiencies	0.000	0.997	0.003
E63.1 Imbalance of constituents of food intake	0.000	0.997	0.003
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.997	0.003
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.997	0.003
E64.8 Sequelae of other nutritional deficiencies	0.000	0.997	0.003
E64.3 Sequelae of rickets	0.000	0.997	0.003
E64.2 Sequelae of vitamin C deficiency	0.000	0.997	0.003
E64.1 Sequelae of vitamin A deficiency	0.000	0.997	0.003
E64.0 Sequelae of protein-energy malnutrition	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
R34 Anuria and oliguria	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
R35 Polyuria	0.003	0.997	0.000
E04.8 Other specified non-toxic goitre	0.000	0.997	0.003
J32.2 Chronic ethmoidal sinusitis	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
J32 Chronic sinusitis	0.003	0.997	0.000
E51.9 Thiamine deficiency, unspecified	0.000	0.997	0.003
E51.8 Other manifestations of thiamine deficiency	0.000	0.997	0.003
E51.1 Beriberi	0.000	0.997	0.003
T39.0 Salicylates	0.003	0.997	0.000
K91.4 Colostomy and enterostomy malfunction	0.000	0.997	0.003
R30.1 Vesical tenesmus	0.003	0.997	0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.000	0.997	0.003
G45.9 Transient cerebral ischaemic attack, unspecified	0.000	0.997	0.003
G45.4 Transient global amnesia	0.000	0.997	0.003
K25.4 Chronic or unspecified with haemorrhage	0.000	0.997	0.003
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.997	0.003
E11.8 With unspecified complications	0.000	0.997	0.003
E20.9 Hypoparathyroidism, unspecified	0.000	0.997	0.003
E11.1 With ketoacidosis	0.000	0.997	0.003
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations